Initial combination therapy with olmesartan/hydrochlorothiazide in moderate-to-severe hypertension

被引：0
|
作者：
L C Rump
E Ambrosioni
M Burnier
W Hörl
A J Rabelink
机构：
[1] Klinikum der Ruhr-Universität Bochum,Division of Internal Medicine
[2] Marienhospital Herne,undefined
[3] St Orsola Hospital University of Bologna,undefined
[4] Service de Néphrologie,undefined
[5] Centre Hospitalier Universitaire Vaudois,undefined
[6] Innere Medizin III/AKH,undefined
[7] Leiden University Medical Center,undefined
来源：
Journal of Human Hypertension | 2006年 / 20卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：299 / 301
页数：2
相关论文
共 50 条
  • [31] Amlodipine/valsartan/hydrochlorothiazide triple combination therapy in moderate/severe hypertension: Secondary analyses evaluating efficacy and safety
    David A. Calhoun
    Nora A. Crikelair
    Joseph Yen
    Robert D. Glazer
    Advances in Therapy, 2009, 26 : 1012 - 1023
  • [32] Amlodipine/valsartan/hydrochlorothiazide triple combination therapy in moderate/severe hypertension: Secondary analyses evaluating efficacy and safety
    Calhoun, David A.
    Crikelair, Nora A.
    Yen, Joseph
    Glazer, Robert D.
    ADVANCES IN THERAPY, 2009, 26 (11) : 1012 - 1023
  • [33] Aliskiren/Hydrochlorothiazide Combination In Mild to Moderate Hypertension
    Baldwin, Claudine M.
    Plosker, Greg L.
    DRUGS, 2009, 69 (07) : 833 - 841
  • [34] Efficacy of olmesartan/amlodipine combination therapy in reducing ambulatory blood pressure in moderate-to-severe hypertensive patients not controlled by amlodipine alone
    Grzegorz Bilo
    Winfried Koch
    Satoshi Hoshide
    Gianfranco Parati
    Hypertension Research, 2014, 37 : 836 - 844
  • [35] ADDING HYDROCHLOROTHIAZIDE PROVIDES DOSE-DEPENDENT SEATED BLOOD PRESSURE REDUCTIONS IN PATIENTS WITH MODERATE-TO-SEVERE HYPERTENSION NOT CONTROLLED BY OLMESARTAN MEDOXOMIL 40MG
    Rump, L.
    Sellin, L.
    Ammentorp, B.
    Schmitt, J.
    Laeis, P.
    JOURNAL OF HYPERTENSION, 2010, 28 : E109 - E110
  • [36] Erratum to: Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial
    Il Suk Sohn
    Chong-Jin Kim
    Byung-Hee Oh
    Taek-Jong Hong
    Chang-Gyu Park
    Byung-Soo Kim
    Woo-Baek Chung
    American Journal of Cardiovascular Drugs, 2016, 16 : 139 - 139
  • [37] Olmesartan medoxomil (OLM) plus amlodipine (AML) is well-tolerated in patients with moderate-to-severe hypertension
    Brommer, P.
    Laeis, P.
    Ammentorp, B.
    Haag, U.
    JOURNAL OF HYPERTENSION, 2008, 26 : S473 - S473
  • [38] Efficacy and safety of a fixed combination of irbesartan/ hydrochlorothiazide in Chinese patients with moderate to severe hypertension
    Huang Q.-F.
    Sheng C.-S.
    Li Y.
    Ma G.-S.
    Dai Q.-Y.
    Wang J.-G.
    Drugs in R&D, 2013, 13 (2) : 109 - 117
  • [39] CONCOMITANT THERAPY WITH LABETALOL AND HYDROCHLOROTHIAZIDE IN MODERATE TO MODERATELY SEVERE ESSENTIAL-HYPERTENSION
    KOCHAR, MS
    TYSON, J
    KALBFLEISCH, JH
    JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 25 (06): : 433 - 436
  • [40] Olmesartan Medoxomil/Amlodipine/Hydrochlorothiazide Fixed-Dose Combination in Hypertension
    Deeks, Emma D.
    DRUGS, 2011, 71 (02) : 209 - 220
12345